Power Law company profile

PolyNovo

Biotech & Life Sciences · Melbourne, Australia · Founded 1998 · IPO 1999 Unicorn

Developer and manufacturer of biodegradable polymer. The company's products are used to reconstruct or repair failed tissue, enabling patients to get their desired strength back

Valuation

$964M

Market cap · 2026

Revenue

$68M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $1B+ revenueColt · Power Law growth-stage

Investors

1 investor on PolyNovo's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 1 investor entered at this stage

Monash University

Global footprint

Where PolyNovo has talent and traffic

Workforce by country

9 countries with
team presence

🇺🇸 United States43.9%

🇦🇺 Australia42.4%

🇮🇳 India7.6%

🇬🇧 United Kingdom3%

🇳🇿 New Zealand1.2%

Top 5 of 9 shown

Patent intelligence

$15M patent portfolio · 7 active families

Estimated portfolio value

$15M

1.5% of market cap · 27.8× smaller than top peer NovoCure ($409M)

7 active patent families

Where PolyNovo innovates Polymer chemistryBiodegradable polyurethaneTissue engineeringBiodegradationBiomedical engineering

Where PolyNovo concentrates vs peers

Each axis is a top-10 topic across PolyNovo and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about PolyNovo

An AI-synthesized read of the highest-engagement posts about PolyNovo on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See PolyNovo on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles